Professional Documents
Culture Documents
1
1
Table of Contents
1.0 Introduction: 3
2.0 Literature Review: 4
3.0 Impact of Industry 4.0 on Pfizer: 6
References: 10
1.0 Introduction:
Pfizer, a leading multinational pharmaceutical company with an 8.2% market share in the UK
pharmaceutical market, has witnessed significant growth since its establishment in 1849.
Employing around 88,300 people globally and operating in 125 countries, Pfizer focuses on
developing medicines and vaccines across various medical disciplines. This report explores the
impact of Industry 4.0 on Pfizer's supply chain operations.
The advent of Industry 4.0 has brought about substantial changes in various industries, including
pharmaceuticals. This research delves into the origins of Industry 4.0, or the Fourth Industrial
Revolution, and critically assesses its effects on Pfizer's supply chain.
The Fourth Industrial Revolution, marked by smart factories and automation, has substantially
improved manufacturing efficiency, introducing agility and flexibility. This section critically
analyzes its impact on Pfizer's supply chain operations.
Previously, Pfizer's supply chain operations were slower, relying on traditional communication
methods for order placement and evaluation of stocks. Industry 4.0 technologies have enabled
Pfizer to enhance efficiency, particularly in inventory management, demand forecasting, and
production planning.
Utilizing technologies like online ordering systems, Pfizer has aimed to streamline processes.
However, challenges persist in fully leveraging the potential of these advancements. Integrating
real-time tracking options and IoT, such as RFID chips, could further enhance Pfizer's supply
chain, providing healthcare providers with improved visibility and control.